Ondansetron Aurobindo 8 mg Filmtabletten, Dexamethasone 4 mg tablets, ZYPREXA 2.5 mg coated tablets, SELINEXOR, Bortezomib Accord 3.5 mg powder for solution for injection
XPORT-MM-028
Phase 2 small_molecule active
Quick answer
Ondansetron Aurobindo 8 mg Filmtabletten, Dexamethasone 4 mg tablets, ZYPREXA 2.5 mg coated tablets, SELINEXOR, Bortezomib Accord 3.5 mg powder for solution for injection for Penta-refractory multiple myeloma and triple-class refractory multiple myeloma is a Phase 2 program (small_molecule) at Karyopharm Therapeutics with 1 ClinicalTrials.gov record(s).
Program details
- Company
- Karyopharm Therapeutics
- Indication
- Penta-refractory multiple myeloma and triple-class refractory multiple myeloma
- Phase
- Phase 2
- Modality
- small_molecule
- Status
- active